Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: February 2023

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) NanoAb Product Shows Preclinical Promise as COVID Preventative for consumers Hit by Evusheld’s EUA Withdrawal

Posted on February 22, 2023 by MissionIR

Pioneering immunotherapy developer BiondVax Pharmaceuticals (NASDAQ: BVXV) is seeing convincingly positive outcomes for preventing and arresting disease in COVID patients during an ongoing preclinical in vivo study, even as continually evolving variants of the COVID virus are shutting down emergency … Continue reading →

Posted in BiondVax Pharmaceuticals Ltd. BVXV | Leave a comment

MissionIRNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) CEO Featured in Recent “Authority” Magazine Interview

Posted on February 21, 2023 by MissionIR

HeartBeam (NASDAQ: BEAT) CEO and founder Branislav Vajdic, PhD, is featured in a recent interview with David Leichner that was published in “Authority” magazine. The interview was one of a series of interviews with leaders of tech companies. The series, … Continue reading →

Posted in HeartBeam Inc. BEAT | Leave a comment

MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Releases Findings from Hypertension Study

Posted on February 21, 2023 by MissionIR

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, is reporting additional findings from its human clinical study HYPER-H21-4; the study is designed to demonstrate a potentially novel mechanism of action of LEXX’s patented DehydraTECH-processed cannabidiol (“CBD”) capsule formulation … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

MissionIRNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Announces Results of Annual Meeting of Stockholders

Posted on February 21, 2023 by MissionIR

FingerMotion (NASDAQ: FNGR), a mobile data and services company, today announced the outcome of matters voted on at its recent annual meeting of stockholders, which took place on Feb. 17, 2023. Among the highlights, Hsien Loong Wong, Yew Poh Leong, … Continue reading →

Posted in FingerMotion Inc. FNGR | Leave a comment

MissionIRNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Secures Multiple Contracts for Processing Organics at Sea to Sky Soils

Posted on February 21, 2023 by MissionIR

EverGen (TSX.V: EVGN) (OTCQB: EVGIF) announced that its Sea to Sky Soils organic waste processing and composting facility has entered multiple contracts with a B.C. regional district for the processing of organic waste at the facility, which provides over 10,000 … Continue reading →

Posted in EverGen Infrastructure Corp. EVGIF | Leave a comment

HeartBeam Inc. (NASDAQ: BEAT) Supports American Heart Month with Commitment to Provide Solutions

Posted on February 21, 2023 by MissionIR

Following a decades-long tradition, President Joseph Biden issued a proclamation from the White House declaring February as American Heart Month (https://ibn.fm/6Z9Iq). This nationwide focus on heart health is fully supported by HeartBeam (NASDAQ: BEAT), a cardiac technology company dedicated to … Continue reading →

Posted in HeartBeam Inc. BEAT | Leave a comment

MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Builds on Growing Success with Sales of New K1 Call Boxes

Posted on February 21, 2023 by MissionIR

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, sees continued growth through sales of 11 K1 Call Boxes to Larimer County, Colorado. The transaction was completed through KSCP resale partner Stream Speed … Continue reading →

Posted in Knightscope Inc. KSCP | Leave a comment

MissionIRNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Q2 2023 Financial, Corporate Report

Posted on February 21, 2023 by MissionIR

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, is reporting on its second quarter of fiscal year 2023, the period that ended Dec. 31, 2022. Highlights of the report … Continue reading →

Posted in InMed Pharmaceuticals Inc. INM | Leave a comment

Lexaria Bioscience Corp. (NASDAQ: LEXX) Continues to Foster New Partnerships with its Expanding DehydraTECH(TM) Licensing Opportunities

Posted on February 21, 2023 by MissionIR

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, has, since 2016, repeatedly demonstrated the potential of its patented technology, DehydraTECH(TM). The technology improves how active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting healthier oral ingestion methods … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) Transforms Organic Waste to Energy While Developing Canada’s RNG Network

Posted on February 21, 2023 by MissionIR

Agricultural digestion produces biogas by breaking down organic matter such as livestock manure, crop residues, and food waste. The biogas is then purified of water vapor, sulfide, siloxanes, and hydrogen sulfide to create renewable natural gas – an environmentally friendly … Continue reading →

Posted in EverGen Infrastructure Corp. EVGIF | Leave a comment